210 related articles for article (PubMed ID: 15182601)
1. Clopidogrel: how good is it and how does it work?
Santa-Cruz RA; Steinhubl SR
Curr Cardiol Rep; 2004 Jul; 6(4):264-8. PubMed ID: 15182601
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and clopidogrel: a sweeping combination in cardiology.
Manolis AS; Tzeis S; Andrikopoulos G; Koulouris S; Melita H
Curr Med Chem Cardiovasc Hematol Agents; 2005 Jul; 3(3):203-19. PubMed ID: 15974885
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel but not aspirin reduces P-selectin expression and formation of platelet-leukocyte aggregates in patients with atherosclerotic vascular disease.
Klinkhardt U; Bauersachs R; Adams J; Graff J; Lindhoff-Last E; Harder S
Clin Pharmacol Ther; 2003 Mar; 73(3):232-41. PubMed ID: 12621388
[TBL] [Abstract][Full Text] [Related]
4. Aspirin and clopidogrel resistance-a myth or reality: an update.
Gupta S; Gupta MM
Indian Heart J; 2008; 60(3):245-53. PubMed ID: 19240315
[No Abstract] [Full Text] [Related]
5. Clopidogrel but not Aspirin prevents acute smoking-induced platelet aggregation in patients with stable coronary artery disease.
Addad F; Chakroune T; Asma A; Abderazek F; Zohra D; Ghrissi I; Hassine M; Gamra H; Elalamy I
Thromb Res; 2009 Feb; 123(4):640-3. PubMed ID: 18602138
[No Abstract] [Full Text] [Related]
6. Variability in platelet response to the antiplatelet agents aspirin and clopidogrel: mechanisms, measurement, and clinical relevance.
Jennings LK
Crit Pathw Cardiol; 2009 Mar; 8(1):20-8. PubMed ID: 19258834
[TBL] [Abstract][Full Text] [Related]
7. Response to letter regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
Fujisue K; Sugiyama S; Ono T; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Kaikita K; Iwashita S; Sumida H; Hokimoto S; Oniki K; Nakagawa K; Matsui K; Ogawa H
Circ Cardiovasc Interv; 2013 Oct; 6(5):e66. PubMed ID: 24129939
[No Abstract] [Full Text] [Related]
8. Letter by Mangiacapra and Barbato regarding article, "Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease".
Mangiacapra F; Barbato E
Circ Cardiovasc Interv; 2013 Oct; 6(5):e65. PubMed ID: 24129938
[No Abstract] [Full Text] [Related]
9. Effects of endothelial dysfunction on residual platelet aggregability after dual antiplatelet therapy with aspirin and clopidogrel in patients with stable coronary artery disease.
Fujisue K; Sugiyama S; Ono T; Matsuzawa Y; Akiyama E; Sugamura K; Matsubara J; Kurokawa H; Kaikita K; Iwashita S; Sumida H; Hokimoto S; Oniki K; Nakagawa K; Matsui K; Ogawa H
Circ Cardiovasc Interv; 2013 Aug; 6(4):452-9. PubMed ID: 23922147
[TBL] [Abstract][Full Text] [Related]
10. Platelet resistance to antiplatelet drugs.
Kumar A; Kao J
Recent Pat Cardiovasc Drug Discov; 2009 Jun; 4(2):98-108. PubMed ID: 19519552
[TBL] [Abstract][Full Text] [Related]
11. Aspirin and clopidogrel resistance: possible mechanisms and clinical relevance. Part I: Concept of resistance.
Vadász D; Sztriha LK; Sas K; Vecsei L
Ideggyogy Sz; 2012 Nov; 65(11-12):377-85. PubMed ID: 23289172
[TBL] [Abstract][Full Text] [Related]
12. [Combination of clopidogrel and aspirin was no better than aspirin alone for prevention of atherothrombotic events in stable patients. Results of CHARISMA].
Granitskiĭ NA
Kardiologiia; 2006; 46(5):73-5. PubMed ID: 16858363
[No Abstract] [Full Text] [Related]
13. Role of clopidogrel in managing atherothrombotic cardiovascular disease.
Eshaghian S; Kaul S; Amin S; Shah PK; Diamond GA
Ann Intern Med; 2007 Mar; 146(6):434-41. PubMed ID: 17371888
[TBL] [Abstract][Full Text] [Related]
14. Combined antiplatelet therapy: still a sweeping combination in cardiology.
Manolis AS; Manolis TA; Papadimitriou P; Koulouris S; Melita H
Cardiovasc Hematol Agents Med Chem; 2013 Jun; 11(2):136-67. PubMed ID: 23597106
[TBL] [Abstract][Full Text] [Related]
15. Effects of diabetes mellitus on platelet reactivity after dual antiplatelet therapy with aspirin and clopidogrel.
van Werkum JW; Topcu Y; Postma S; Kelder JC; Hackeng CM; ten Berg JM; Verheugt FW
Thromb Haemost; 2008 Mar; 99(3):637-9. PubMed ID: 18327417
[No Abstract] [Full Text] [Related]
16. [Difficulties in evaluating the efficacy of antiplatelet therapy in clinical practice].
Buriachkovskaia LI; Uchitel' IA; Sumarokov AV; Popov EG
Ter Arkh; 2009; 81(5):41-7. PubMed ID: 19537585
[TBL] [Abstract][Full Text] [Related]
17. Clopidogrel and risk for acute coronary events.
Mood GR; Bhatt DL
Curr Atheroscler Rep; 2007 Nov; 9(5):401-8. PubMed ID: 18001624
[TBL] [Abstract][Full Text] [Related]
18. Assessment, mechanisms, and clinical implication of variability in platelet response to aspirin and clopidogrel therapy.
Ben-Dor I; Kleiman NS; Lev E
Am J Cardiol; 2009 Jul; 104(2):227-33. PubMed ID: 19576352
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel and aspirin in cardiovascular medicine: responders or not--current best available evidence.
Tourmousoglou CE; Rokkas CK
Cardiovasc Hematol Agents Med Chem; 2008 Oct; 6(4):312-22. PubMed ID: 18855644
[TBL] [Abstract][Full Text] [Related]
20. Contemporary use of clopidogrel in patients with coronary artery disease.
Parikh SA; Beckman JA
Curr Cardiol Rep; 2007 Jul; 9(4):257-63. PubMed ID: 17601391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
